Thymidylate synthase (ThS) is a target for antimetabolite antitumor
drugs. Such
drugs have been
AKHMETOVA, V.R.,
AKHMADIEV, N.S.,
NURTDINOVA, G.M.,
GALIMOVA, R.A.,
GALIMOVA, A.M.,
AGLETDINOV, E.F.,
KATAEV, V.A.,
KHISAMUTDINOV, R.A. (2018) -adenosyl-L-methionine), formed in the biosynthetic process, is
used as an effective
hepatoprotective
drug. Complexation
STARODUBOV, V.I.,
MARCZAK, L.B.,
VARAVIKOVA, E.,
BIKBOV, B.,
ERMAKOV, S.P.,
GALL, J.,
GLENN, S.D.,
GRISWOLD, M.,
IDRISOV, B.,
KRAVCHENKO, M.,
LIOZNOV, D.,
LOYOLA, E.,
RAKOVAC, I.,
VLADIMIROV, S.K.,
VLASSOV, V.,
MURRAY, C.J.L.,
NAGHAVI, M (2018) to behavioural risk factors, including alcohol
use,
drug use, and smoking.
Interpretation Trends in mortality